What did @mypeptideslab actually say?
Straightforwardly: the transcript provided for this video is not coherent peptide content. The words attributed to the creator read as garbled, likely auto-transcribed audio from a completely unrelated source. Phrases like "I currently have been rich for a long time" and "you can play a lot of games in your game" have zero connection to BPC-157, TB-500, GHK-Cu, or any peptide science. The caption promises a reframe of how viewers think about peptide selection. The transcript delivers none of that.
This matters because we cannot fact-check claims that were not legibly captured. What we can do is evaluate what the caption and hashtags imply, and what creators in this space typically argue when they say you are "looking at it wrong" when choosing a peptide.
Does the science back up the implied framing?
The implied argument, common in peptide content, is that people fixate on individual peptides rather than on their underlying biology, goals, or healing pathways. That framing is not wrong, but it is also not well-supported by clinical literature, because most peptides in this category have never been tested in rigorous human trials.
BPC-157 has a growing body of animal research suggesting effects on tendon and gut healing, with Sikiric et al. (2018, Current Pharmaceutical Design) being frequently cited. TB-500, a synthetic fragment of thymosin beta-4, has been studied in cardiac repair contexts, with Bock-Marquette et al. (2004, Nature) showing effects in cardiac muscle. GHK-Cu has copper-binding and wound-healing data, reviewed by Pickart and Margolina (2018, Symmetry). But none of these peptides have completed Phase III human clinical trials for the uses promoted in this content category. That gap is significant and almost never disclosed.
What did they get wrong, or right?
Because the transcript is incoherent, we cannot credit or fault the creator for specific factual claims. What we can say is that the caption framing, "you're looking at it wrong," is a common rhetorical move in the peptide influencer space. Sometimes it leads to genuinely useful systems thinking about inflammation, recovery, and biological context. More often it is a setup to recommend a stack of products the creator sells or is affiliated with.
The hashtags BPC-157, TB-500, and GHK-Cu together suggest the video is positioning these as complementary rather than individual choices. Combining peptides without clinical guidance is not inherently dangerous in every case, but the evidence base for combination protocols is essentially nonexistent. No peer-reviewed study has tested BPC-157 plus TB-500 plus GHK-Cu together in humans. Recommending stacks based on anecdote and community lore is not the same as evidence-based guidance.
What should you actually know?
If you are exploring peptide therapy, the honest state of the evidence is this: animal data is promising for several compounds, human trial data is sparse, and regulatory status varies significantly by country and compound. In the United States, many of these peptides are not FDA-approved for therapeutic use and are sold as research chemicals, which creates real quality-control concerns.
Compounded peptides from telehealth platforms operate under different regulatory frameworks than FDA-approved drugs. That is not automatically a reason to avoid them, but it is a reason to ask hard questions about sourcing, purity testing, and clinical oversight. A video that tells you which peptide to take without knowing your labs, your history, or your goals is not medical guidance. It is content.
Work with a licensed provider who can review your specific situation before starting any peptide protocol. The "systems thinking" framing some creators use is actually reasonable as a starting point. The problem is when it skips the step where a clinician is involved.